All research
Tirzepatide 2026-09-15 PubMed

Real-World Evidence for Existing Anti-Obesity Therapies-The Realities of Treatment Adherence, Tolerability, Access and Patient Satisfaction.


Summary withdrawn

TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.


obesity semaglutide tirzepatide incretin-agonist weight-loss adherence
Source: pubmed:42736522 · Ingested Sep 15, 2026